Takeji, Yasuaki
Taniguchi, Tomohiko
Morimoto, Takeshi
Shirai, Shinichi
Kitai, Takeshi
Tabata, Hiroyuki
Kitano, Kazuki
Ohno, Nobuhisa
Murai, Ryosuke
Osakada, Kohei
Murata, Koichiro
Nakai, Masanao
Tsuneyoshi, Hiroshi
Tada, Tomohisa
Amano, Masashi
Watanabe, Shin
Shiomi, Hiroki
Watanabe, Hirotoshi
Yoshikawa, Yusuke
Nishikawa, Ryusuke
Yamamoto, Ko
Obayashi, Yuki
Toyofuku, Mamoru
Tatsushima, Shojiro
Kanamori, Norio
Miyake, Makoto
Nakayama, Hiroyuki
Nagao, Kazuya
Izuhara, Masayasu
Nakatsuma, Kenji
Inoko, Moriaki
Fujita, Takanari
Kimura, Masahiro
Ishii, Mitsuru
Usami, Shunsuke
Sawada, Kenichiro
Nakazeki, Fumiko
Okabayashi, Marie
Shirotani, Manabu
Inuzuka, Yasutaka
Ando, Kenji
Komiya, Tatsuhiko
Minatoya, Kenji
Kimura, Takeshi
,
Article History
Received: 8 February 2023
Accepted: 6 June 2023
First Online: 22 June 2023
Declarations
:
: Dr. Shiomi reports personal fees from Abbott Vascular, Boston Scientific, and Daiichi Sankyo. Dr. Morimoto reports lecturer's fees from Bristol-Myers Squibb, Daiichi Sankyo, Japan Lifeline, Kowa, Kyocera, Novartis, and Toray; manuscript fees from Bristol-Myers Squibb and Kowa; advisory board for Sanofi. Dr. Kimura reports advisory board for Abbott Vascular; grants from Edwards Lifescience, Daiichi Sankyo, Takeda Pharmaceutical, Bayer, Otsuka Parmaceutical, Boehringer Ingelheim, Mitsubishi Tanabe Pharma, Sumitomo Dainippon Pharma, Kowa, Abiomed, Japan Academic Research Forum, NIPRO, W. L. Gore & Associates G.K., RPM Co.,Ltd., CSL Behring, Pfizer R&D Japan G.K., EP-CRSU Co., Ltd; modest honoraria from MSD, Eisai, Edwards Lifescience, Ono Pharmaceutical, Tsumura, Medical Review, Kowa, Sanofi, Pharmaceuticals and Medical Devices Agency, Bristol-Myers Squibb, Boston Scientific, Lifescience, Toray, Astellas Amgen Biopharma, Astellas, AstraZeneca, OrbusNeich, MSD Life Science Foundation, Public Health Research Foundation, Chugai Pharmaceutical, Japan Society for the Promotion of Science, Interscience, Philips, Kowa Pharmaceutical, Mitsubishi Tanabe Pharma, Terumo, Novartis Pharma, HeartFlow Japan G.K., CROSSCO Co.
: The present study was approved by Kyoto University Graduate School and Faculty of Medicine Ethics Committee.